Abiraterona en cáncer de próstata hormono-sensible metastásico

3 / 32

mHSPC
mCRPC
L2
mCRPC
L2+
Localized
Disease
25%
High
Risk
Newly Diagnosed
M0-CRPC
Potential Cure
mCRPC
L1
Biochemical
Recurrence
Abiraterone LATITUDE
m1HNPC (HR)
Label Jan-18
Abiraterone mCRPC
2011 (L2) /2013 (L1)